SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Sep 30, 2015	View HTML 0001193125-15-334070.pdf 0001193125-15-334070.rtf 0001193125-15-334070.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Oct 07, 2016	View HTML 0001193125-16-733073.pdf 0001193125-16-733073.rtf 0001193125-16-733073.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	May 04, 2017	View HTML 0001193125-17-158739.pdf 0001193125-17-158739.rtf 0001193125-17-158739.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Nov 03, 2017	View HTML 0001193125-17-333025.pdf 0001193125-17-333025.rtf 0001193125-17-333025.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Apr 26, 2018	View HTML 0001193125-18-135253.pdf 0001193125-18-135253.rtf 0001193125-18-135253.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Apr 17, 2020	View HTML 0001564590-20-017306.pdf 0001564590-20-017306.rtf 0001564590-20-017306.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Oct 06, 2020	View HTML 0001564590-20-045941.pdf 0001564590-20-045941.rtf 0001564590-20-045941.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Sep 16, 2022	View HTML 0000950170-22-018607.pdf 0000950170-22-018607.rtf 0000950170-22-018607.xls
REGDEX	REGDEX	Mar 06, 2007	View HTML
REGDEX	REGDEX	Dec 01, 2005	View HTML

Data provided by Kaleidoscope.